Wednesday, April 15, 2020

A stopgap measure to treat respiratory distress

Good news! It looks like another well known medication (besides e.g. chloroquine its variants) is going to be applied to severe Covid-19 cases. It's tPA (Tissue plasminogen activator) hooray!

Tissue Plasminogen Activator (tPA) Treatment for COVID‐19 Associated Acute Respiratory Distress Syndrome (ARDS): A Case Series

A stopgap measure to treat respiratory distress | MIT News: Researchers at MIT and the University of Colorado at Denver propose a stopgap measure to help Covid-19 patients in acute respiratory distress: a drug called tissue plasminogen activator, which dissolves blood clots.

No comments: